Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-18-009503
Filing Date
2018-08-08
Accepted
2018-08-08 06:01:36
Documents
7
Period of Report
2018-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp94327_6k.htm 6-K 14825
2 EXHIBIT 3.1 dp94327_ex0301.htm EX-3.1 326864
3 EXHIBIT 99.1 dp94327_ex9901.htm EX-99.1 236945
4 EXHIBIT 99.2 dp94327_ex9902.htm EX-99.2 117349
5 EXHIBIT 99.3 dp94327_ex9903.htm EX-99.3 68339
6 GRAPHIC image_001.jpg GRAPHIC 10680
7 GRAPHIC image_002.jpg GRAPHIC 53376
  Complete submission text file 0000950103-18-009503.txt   853689
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 18999660
SIC: 2834 Pharmaceutical Preparations